Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis of?randomized controlled trials.

已完结 10 由大三发布于 2026/9/28 15:01:15

DOI:10.1080/1120009X.2025.2595811
作者：Sheng-Yen Hsiao,?Wei-Ting Lin,?Cheng-Yao Lin,?Chien-Ming Chao,?Teng-Song Weng
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Breast cancer is the most common malignancy, with approximately ∼20% of cases involving HER2 overexpression. Trastuzumab deruxtecan (T-DXd), an HER2-targeted antibody-drug conjugate, is appr

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierScreening and effects of intestinal probiotics on growth performance, gut health, immunity, and disease resistance of Nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae